AIG
ODT

American International Group’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

American International Group’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-9,149
Closed -$31 – 3368
2021
Q1 		$31 Buy
9,149
+25
+0.3% +$472 ﹤0.01% 3084
2020
Q4 		$175 Buy
9,124
+1,305
+17% +$20.1K ﹤0.01% 2353
2020
Q3 		$105K Sell
7,819
-178
-2% -$5.04K ﹤0.01% 2511
2020
Q2 		$339K Buy
7,997
+2,305
+40% +$74.6K ﹤0.01% 1802
2020
Q1 		$157K Sell
5,692
-1,651
-22% -$48.1K ﹤0.01% 2045
2019
Q4 		$238K Sell
7,343
-61
-0.8% -$1.89K ﹤0.01% 2110
2019
Q3 		$193K Buy
7,404
+2,472
+50% +$82.7K ﹤0.01% 2185
2019
Q2 		$181K Buy
4,932
+607
+14% +$14.5K ﹤0.01% 2294
2019
Q1 		$96K Sell
4,325
-140
-3% -$2.45K ﹤0.01% 2643
2018
Q4 		$63K Sell
4,465
-35
-0.8% -$545 ﹤0.01% 2801
2018
Q3 		$87K Buy
4,500
+81
+2% +$1.65K ﹤0.01% 2906
2018
Q2 		$98K Buy
4,419
+98
+2% +$2.28K ﹤0.01% 2802
2018
Q1 		$92K Buy
+4,321
New +$102K ﹤0.01% 2700

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

American International Group's ODT Position: Q2 2021 in Review

American International Group sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q2 2021, closing a stake of 9,149 shares — an estimated $31 sold.

American International Group first reported a position in ODT in Q1 2018 and held it in 13 quarters. The position peaked at $339K in Q2 2020. 69 funds tracked by Wall St. Rank hold ODT as of Q2 2021.

  • American International Group reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • American International Group sold 9,149 Odonate Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $31.
  • American International Group first reported a position in Odonate Therapeutics, Inc. Common Stock in Q1 2018 and held it in 13 quarters.
  • American International Group's Odonate Therapeutics, Inc. Common Stock position peaked at $339K in Q2 2020.
  • 69 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.